STAT3 and nonpapillary renal cell carcinoma: (2022) demonstrated that IL-1RII can also promote oncogenic signaling by activating the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway in clear cell renal cell carcinoma (ccRCC) (58, 59).